Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | UBE2L6 |
| Upstream (Parents) |
|---|
| (<<) CDK8 → UBE2L6 |
| (<<) CSTA → UBE2L6 |
| (<<) CYB5R3 → UBE2L6 |
| (<<) DDR1 → UBE2L6 |
| (<<) FAS → UBE2L6 |
| (<<) HDAC2 → UBE2L6 |
| (<<) IL1R1 → UBE2L6 |
| (<<) MAPKAPK5 → UBE2L6 |
| (<<) PLCG2 → UBE2L6 |
| (<<) ST3GAL1 → UBE2L6 |
| (<<) TNFRSF1A → UBE2L6 |
| Downstream (Children) |
|---|
| UBE2L6 → ARHGAP25 (>>) |
| UBE2L6 → BLNK (>>) |
| UBE2L6 → CASP1 (>>) |
| UBE2L6 → CHI3L1 (>>) |
| UBE2L6 → DUSP1 (>>) |
| UBE2L6 → EIF6 (>>) |
| UBE2L6 → GBP2 (>>) |
| UBE2L6 → GLRX (>>) |
| UBE2L6 → GYPC (>>) |
| UBE2L6 → ICAM1 (>>) |
| UBE2L6 → IFITM3 (>>) |
| UBE2L6 → JHDM1D (>>) |
| UBE2L6 → KYNU (>>) |
| UBE2L6 → MYL7 (>>) |
| UBE2L6 → PRKCB (>>) |
| UBE2L6 → PTK2 (>>) |
| UBE2L6 → ROCK2 (>>) |
| UBE2L6 → STAT1 (>>) |
| UBE2L6 → STAT4 (>>) |
| UBE2L6 → SYNJ2 (>>) |
| UBE2L6 → TYK2 (>>) |
| UBE2L6 → VAV3 (>>) |
